These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 92577)

  • 21. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
    Sakamoto K; Hinuma Y
    J Immunol; 1978 May; 120(5):1702-8. PubMed ID: 207776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides.
    North JR; Morgan AJ; Epstein MA
    Int J Cancer; 1980 Aug; 26(2):231-40. PubMed ID: 6162806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large-scale purification of Epstein-Barr virus membrane antigen gp340 with a monoclonal antibody immunoabsorbent.
    Randle BJ; Morgan AJ; Stripp SA; Epstein MA
    J Immunol Methods; 1985 Feb; 77(1):25-36. PubMed ID: 2579161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis.
    Strnad BC; Schuster TC; Hopkins RF; Neubauer RH; Rabin H
    J Virol; 1981 Jun; 38(3):996-1004. PubMed ID: 7017165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.
    Pearson GR; Vroman B; Chase B; Sculley T; Hummel M; Kieff E
    J Virol; 1983 Jul; 47(1):193-201. PubMed ID: 6306272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
    Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
    J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
    Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
    Hoffman GJ; Lazarowitz SG; Hayward SD
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of Epstein-Barr virus-related surface polypeptides expressed on n-butyrate-treated P3HR-1 cells.
    Kawanishi M; Sugawara K; Ito Y
    Intervirology; 1983; 19(3):162-8. PubMed ID: 6299996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines.
    Luka J; Lindahl T; Klein G
    J Virol; 1978 Sep; 27(3):604-11. PubMed ID: 212583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.
    Sculley TB; Sculley DG; Pope JH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1113-22. PubMed ID: 2582083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit.
    Luka J; Jörnvall H; Klein G
    J Virol; 1980 Sep; 35(3):592-602. PubMed ID: 6158579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
    Vestergaard BF; Hesse J; Norrild B; Klein G
    Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.
    Thorley-Lawson DA
    Cell; 1979 Jan; 16(1):33-42. PubMed ID: 217544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
    Takada K; Fujiwara S; Yano S; Osato T
    Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
    Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K; Harada M; Sairenji T; Hinuma Y
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.